Toulon P, Eloit Y, Smahi M, Sigaud C, Jambou D, Fischer F, Appert-Flory A
Faculté de Médecine, Laboratoire d'Hématologie, Université Nice Sophia-Antipolis, Nice, France.
CHU, Hôpital Pasteur, Service d'Hématologie Biologique, Nice, France.
Int J Lab Hematol. 2016 Aug;38(4):389-96. doi: 10.1111/ijlh.12499. Epub 2016 May 17.
Activated partial thromboplastin time (aPTT) is a routine clotting assay that is widely used to globally screen for coagulation abnormalities. It is commonly admitted that a prolonged test result, may trigger the need for specific assays to be performed, particularly factor measurement. However, the sensitivity of aPTT reagents to deficiencies of clotting factors varies.
We evaluated, according to the recommendation of the CLSI H47-A2 guideline, the responsiveness to single factor levels of five aPTT reagents by using factor-deficient plasmas spiked with a calibration plasma to produce individual factor activities ranging from <1 to ~100 Unit (U)/dL. Test results were expressed as the sample-to-control ratio, the latter was defined as the clotting time obtained in the calibration plasma containing ~100 U/dL factor activity. The factor activity producing a prolongation of aPTT above the upper limit of its specific normal range (in ratio) was assigned as the factor responsiveness in U/dL to that reagent.
Responsiveness ranged from 34 to 47 U/dL to
C, from 18 to 57 U/dL to FIX, from 38 to 52 U/dL to FXI, from 29 to 50 U/dL to FXII, from 40 and 59 U/dL to FV, from 7.5 to 49 U/dL to FX, and from 9.1 to 10.5 U/dL to FII.
These results suggest that the sensitivity of the tested aPTT reagents to single factor deficiency is highly variable. Moreover, for one given aPTT reagent, its sensitivity was very different depending on the deficient factor. This must be considered when analyzing clinical materials.
活化部分凝血活酶时间(aPTT)是一种常规凝血检测方法,广泛用于全面筛查凝血异常。人们普遍认为,检测结果延长可能会引发进行特定检测的需求,尤其是因子测定。然而,aPTT试剂对凝血因子缺乏的敏感性各不相同。
根据CLSI H47-A2指南的建议,我们通过向缺乏因子的血浆中加入校准血浆来产生个体因子活性范围从<1至约100单位(U)/dL,评估了五种aPTT试剂对单一因子水平的反应性。检测结果表示为样本与对照的比值,后者定义为在含有约100 U/dL因子活性的校准血浆中获得的凝血时间。使aPTT延长超过其特定正常范围上限(以比值计)的因子活性被指定为该试剂以U/dL计的因子反应性。
对FVIII:C的反应性范围为34至47 U/dL,对FIX为18至57 U/dL,对FXI为38至52 U/dL,对FXII为29至50 U/dL,对FV为40至59 U/dL,对FX为7.5至49 U/dL,对FII为9.1至10.5 U/dL。
这些结果表明,所测试的aPTT试剂对单一因子缺乏的敏感性差异很大。此外,对于一种给定的aPTT试剂,其敏感性因缺乏的因子而异。在分析临床材料时必须考虑这一点。